Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1961 1
1962 2
1963 4
1964 4
1965 2
1966 1
1967 6
1968 7
1969 3
1970 3
1971 2
1972 3
1975 4
1976 2
1977 10
1978 6
1979 10
1980 7
1981 7
1982 7
1983 6
1984 6
1985 8
1986 4
1987 3
1988 3
1989 1
1990 1
1991 3
1992 5
1993 2
1994 3
1995 5
1996 1
1997 3
1998 7
1999 4
2000 7
2001 5
2002 10
2003 5
2004 14
2005 28
2006 29
2007 28
2008 27
2009 26
2010 24
2011 27
2012 30
2013 28
2014 27
2015 34
2016 30
2017 32
2018 15
2019 16
2020 17
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

542 results
Results by year
Filters applied: . Clear all
Page 1
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small-Cell Lung Cancer.
Haratani K, Hayashi H, Chiba Y, Kudo K, Yonesaka K, Kato R, Kaneda H, Hasegawa Y, Tanaka K, Takeda M, Nakagawa K. Haratani K, et al. Among authors: kaneda h. JAMA Oncol. 2018 Mar 1;4(3):374-378. doi: 10.1001/jamaoncol.2017.2925. JAMA Oncol. 2018. PMID: 28975219 Free PMC article.
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.
Takahashi T, Yamanaka T, Seto T, Harada H, Nokihara H, Saka H, Nishio M, Kaneda H, Takayama K, Ishimoto O, Takeda K, Yoshioka H, Tachihara M, Sakai H, Goto K, Yamamoto N. Takahashi T, et al. Among authors: kaneda h. Lancet Oncol. 2017 May;18(5):663-671. doi: 10.1016/S1470-2045(17)30230-9. Epub 2017 Mar 23. Lancet Oncol. 2017. PMID: 28343976 Clinical Trial.
Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer.
Nishio M, Kato T, Niho S, Yamamoto N, Takahashi T, Nogami N, Kaneda H, Fujita Y, Wilner K, Yoshida M, Isozaki M, Wada S, Tsuji F, Nakagawa K. Nishio M, et al. Among authors: kaneda h. Cancer Sci. 2020 May;111(5):1724-1738. doi: 10.1111/cas.14384. Epub 2020 Apr 14. Cancer Sci. 2020. PMID: 32159882 Free PMC article. Clinical Trial.
B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
Yonesaka K, Haratani K, Takamura S, Sakai H, Kato R, Takegawa N, Takahama T, Tanaka K, Hayashi H, Takeda M, Kato S, Maenishi O, Sakai K, Chiba Y, Okabe T, Kudo K, Hasegawa Y, Kaneda H, Yamato M, Hirotani K, Miyazawa M, Nishio K, Nakagawa K. Yonesaka K, et al. Among authors: kaneda h. Clin Cancer Res. 2018 Jun 1;24(11):2653-2664. doi: 10.1158/1078-0432.CCR-17-2852. Epub 2018 Mar 12. Clin Cancer Res. 2018. PMID: 29530936 Free article.
Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment.
Haratani K, Hayashi H, Tanaka T, Kaneda H, Togashi Y, Sakai K, Hayashi K, Tomida S, Chiba Y, Yonesaka K, Nonagase Y, Takahama T, Tanizaki J, Tanaka K, Yoshida T, Tanimura K, Takeda M, Yoshioka H, Ishida T, Mitsudomi T, Nishio K, Nakagawa K. Haratani K, et al. Among authors: kaneda h. Ann Oncol. 2017 Jul 1;28(7):1532-1539. doi: 10.1093/annonc/mdx183. Ann Oncol. 2017. PMID: 28407039 Free article.
Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors.
Shimizu T, Seto T, Hirai F, Takenoyama M, Nosaki K, Tsurutani J, Kaneda H, Iwasa T, Kawakami H, Noguchi K, Shimamoto T, Nakagawa K. Shimizu T, et al. Among authors: kaneda h. Invest New Drugs. 2016 Jun;34(3):347-54. doi: 10.1007/s10637-016-0347-6. Epub 2016 Mar 22. Invest New Drugs. 2016. PMID: 27000274 Free PMC article. Clinical Trial.
Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
Kubo T, Shinke T, Okamura T, Hibi K, Nakazawa G, Morino Y, Shite J, Fusazaki T, Otake H, Kozuma K, Ioji T, Kaneda H, Serikawa T, Kataoka T, Okada H, Akasaka T; OPINION Investigators. Kubo T, et al. Among authors: kaneda h. Eur Heart J. 2017 Nov 7;38(42):3139-3147. doi: 10.1093/eurheartj/ehx351. Eur Heart J. 2017. PMID: 29121226 Free PMC article. Clinical Trial.
Growth Differentiation Factor-15 (GDF-15) is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients.
Nakajima T, Shibasaki I, Sawaguchi T, Haruyama A, Kaneda H, Nakajima T, Hasegawa T, Arikawa T, Obi S, Sakuma M, Ogawa H, Toyoda S, Nakamura F, Abe S, Fukuda H, Inoue T. Nakajima T, et al. Among authors: kaneda h. J Clin Med. 2019 Oct 1;8(10):1576. doi: 10.3390/jcm8101576. J Clin Med. 2019. PMID: 31581569 Free PMC article.
Association of serum leptin and adiponectin concentrations with echocardiographic parameters and pathophysiological states in patients with cardiovascular disease receiving cardiovascular surgery.
Sawaguchi T, Nakajima T, Haruyama A, Hasegawa T, Shibasaki I, Nakajima T, Kaneda H, Arikawa T, Obi S, Sakuma M, Ogawa H, Takei Y, Toyoda S, Nakamura F, Abe S, Fukuda H, Inoue T. Sawaguchi T, et al. Among authors: kaneda h. PLoS One. 2019 Nov 8;14(11):e0225008. doi: 10.1371/journal.pone.0225008. eCollection 2019. PLoS One. 2019. PMID: 31703113 Free PMC article.
Malformations of ventral induction.
Kanekar S, Shively A, Kaneda H. Kanekar S, et al. Among authors: kaneda h. Semin Ultrasound CT MR. 2011 Jun;32(3):200-10. doi: 10.1053/j.sult.2011.02.012. Semin Ultrasound CT MR. 2011. PMID: 21596276 Review. No abstract available.
542 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback